Association of programmed death ligand ‐1 (PD‐L1) expression with treatment outcomes in patients with BRAF mutation‐positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenib

Pigment Cell&Melanoma Research,Volume 31, Issue 4, Page 516-522, July 2018.

Source: Pigment Cell Research - December 10, 2017 Category: Cytology Authors: Matthew J. Wongchenko , Antoni Ribas , Brigitte Dr éno , Paolo A. Ascierto , Grant A. McArthur , Jorge D. Gallo , Isabelle A. Rooney , Jessie Hsu , Hartmut Koeppen , Yibing Yan , James Larkin Source Type: research